damage, is expressed at very low levels at birth but then increases significantly with age and is highest in adulthood, suggesting that significant changes in complement may occur after brain maturation is complete. Discussion: Together these findings show very dynamic and complex patterns of expression from birth to adulthood, with the most active growth phase and dynamic changes occurring in the early years before adolescence. Thus, an insult during these early years could profoundly affect the developmental trajectory.
FROM DUSK TILL DAWN: LIFELONG TRAJECTORIES OF COGNITIVE FUNCTIONING IN PSYCHOTIC DISORDERS AND THEIR IMPLICATIONS FOR FUNCTIONAL RECOVERY AND TREATMENT DECISION Eva Velthorst Icahn School of Medicine at Mount Sinai
Overall Abstract: This symposium will draw together state of the art findings on the lifelong cognitive trajectories, on key-predictors of cognitive functioning and the functional consequences of cognitive impairments in schizophrenia and related psychotic disorders from developmental epidemiological, prodromal, and clinical research. Four speakers will take the audience through new findings on the cognitive course of the lifespan, ranging from childhood to old age. Specifically, the talks will address four key-questions: 1) Which areas of cognitive functioning are impaired and when does this impairment start? 2) How well can cognitive functioning predict the development of a psychotic illness, as well as diagnostic and functional outcome? 3) Does cognitive functioning remain stable after illness onset or are psychotic disorders characterized by continuing decline? When does decline occur and is it possible to predict it? 4) And what is the functional sequelae of specific cognitive impairments in older adults with schizophrenia?
Specifically, Dr. Mollon will present new data examining the origin of cognitive impairment across the psychosis spectrum using a populationbased cohort followed prospectively from birth. Her findings demonstrate that while individuals with affective psychosis, subthreshold psychotic experiences and even depression experience some degree of cognitive impairment across the first two decades of life, only those who go on to develop non-affective psychosis exhibit large, widespread and increasing deficits. Most studies of neurocognitive functioning in Clinical High Risk (CHR) cohorts have examined group averages, likely concealing heterogeneous subgroups. The study of Dr. Velthorst therefore used two independent methods to identify neurocognitive subgroups in a large population at Clinical High Risk for developing psychosis. Her findings show that neurocognitive profiles vary substantially in their severity and are associated with diagnostic and functional outcome, underscoring neurocognition as a predictor of illness outcomes. Dr. Fett will present recent research on cognitive functioning in a large sample of patients at first hospitalization for a psychotic disorder who have been followed 20-years into the illness. Her findings indicate that cognitive functioning in psychotic disorders continues to decline after illness onset, that this decline is not specific to schizophrenia but present across psychotic disorders, and that, relative to never-psychotic individuals, impairments on some key-cognitive domains worsen with age. Decline could not reliably be predicted by key patient characteristics at baseline. Lastly, Dr. Harvey will share novel data on the course of cognitive functioning in middle aged and older patients with schizophrenia. His findings demonstrate that cognitive impairments are moderated in their impact on everyday outcomes by the presence of severe communication abnormalities. The majority of patients with psychotic disorders experience severe neuropsychological impairment. The onset and course of this impairment, however, is debated. Moreover, the course of neuropsychological functioning in other psychiatric conditions remains largely unexamined. This study used longitudinal data from infancy to early adulthood to chart the course of general and specific neuropsychological functions in individuals with psychotic disorders, psychotic experiences and depression. Methods: Data were from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective cohort study comprising all live births between 1991 and 1992 in Avon, UK. All participants who underwent cognitive testing at 18 months, 4, 8, 15 and 20 years, and psychiatric assessment at age 18 were included. Individuals with non-affective psychotic disorder, affective psychotic disorder, subclinical psychotic experiences and depression were compared to controls on full-scale, verbal and non-verbal IQ, and measures of processing speed, working memory, language, visuospatial ability and attention. Results: Individuals with non-affective psychosis showed continually increasing deficits between infancy (18 months) and adulthood (20 years) in full-scale IQ (effect size of change (ESΔ) =−1.09, p=.02), and non-verbal IQ (ESΔ=−0.94, p=.008). The depression group showed a small, increasing deficit in non-verbal IQ (ESΔ=−0.29, p=.04) between infancy and adulthood. Between ages 8 and 20, the non-affective psychosis group exhibited developmental lags (i.e. slower growth) on measures of processing speed, working memory and attention (ESΔ=−0.68, p=.001; ESΔ=−0.59, p=.004; ESΔ=−0.44, p=.001), and large, static deficits on measures of language and visuospatial ability (ES=−0.87, p=.005; ES=−0.90, p=.001). There was only weak evidence for neuropsychological deficits in individuals with affective psychosis, depression, and subclinical psychotic experiences. Discussion: These findings suggest that the origins of non-affective psychotic disorder involve dynamic neurodevelopmental processes, which effect both verbal and non-verbal abilities throughout the first two decades of life. These neurodevelopmental processes do not manifest in other psychiatric disorders, such as affective psychotic disorder and depression.
